Japan to End Priority Review for COVID Drugs and Vaccines after Severity Downgrade: Official

Yasunori Yoshida, Director, Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW Japan’s Ministry of Health, Labor and Welfare (MHLW) will no longer apply its blanket priority review rule for COVID-19 vaccines and therapeutics once the disease’s severity status...read more